Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1
Toxins · 2024
DOI: 10.3390/toxins16030132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Fang Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, College of Basic Medicine, Hubei Key Laboratory of Embryonic S…. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Wasps. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Science and Technology Department of Hubei Province, Cultivating Project for Young Scholar at the Hubei University of Medicine, National Natural Sciences Foundation of China.
Abstract (Originalsprache)
Viruses are one of the leading causes of human disease, and many highly pathogenic viruses still have no specific treatment drugs. Therefore, producing new antiviral drugs is an urgent matter. In our study, we first found that the natural wasp venom peptide Protopolybia-MP III had a significant inhibitory effect on herpes simplex virus type 1 (HSV-1) replication in vitro by using quantitative real-time PCR (qPCR), Western blotting, and plaque-forming assays. Immunofluorescence analysis showed Protopolybia-MP III could enter cells, and it inhibited multiple stages of the HSV-1 life cycle, including the attachment, entry/fusion, and post-entry stages. Furthermore, ultracentrifugation and electron microscopy detected that Protopolybia-MP III significantly suppressed HSV-1 virion infectivity at different temperatures by destroying the integrity of the HSV-1 virion. Finally, by comparing the antiviral activity of Protopolybia-MP III and its mutants, a series of peptides with better anti-HSV-1 activity were identified. Overall, this work found the function and mechanism of the antiviral wasp venom peptide Protopolybia-MP III and its derivatives against HSV-1 and laid the foundation for the research and development of wasp venom-derived antiviral candidate peptide drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, College of Basic Medicine, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan 442000, China.
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan 442000, China.
- Department of Clinical Laboratory, Dongfeng Hospital, Hubei University of Medicine, Shiyan 442000, China.
ORCID-Profile: Xiangdong Ye, Xudong Luo
Förderung
- Natural Science Foundation of Science and Technology Department of Hubei Province
- Cultivating Project for Young Scholar at the Hubei University of Medicine
- National Natural Sciences Foundation of China
- Natural Science Foundation of the Science and Technology Department of Hubei Province
- Cultivating Project for Young Scholars at the Hubei University of Medicine
Zitieren
APA
Sun, F., Ye, X., Han, T., Xia, J., Wu, L., Zhu, W., Ding, L., Luo, X., Qin, C., & Chen, Z. (2024). Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1. Toxins. https://doi.org/10.3390/toxins16030132
Vancouver
Sun F, Ye X, Han T, Xia J, Wu L, Zhu W, et al. Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1. Toxins. 2024. doi:10.3390/toxins16030132
BibTeX
@article{Sun2024,
author = {Sun, Fang and Ye, Xiangdong and Han, Tanran and Xia, Jingwen and Wu, Lili and Zhu, Wen and Ding, Li and Luo, Xudong and Qin, Chenhu and Chen, Zongyun},
title = {Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16030132}
}
EUVIMED